Cargando…
Tumor-Homing of Mesenchymal Stem Cells Infected with Oncolytic Virus in a Canine Patient
Intravenous administration of oncolytic adenovirus (OAds) can be challenging, although various vehicles for the delivery of the virus to the tumor have been described. The efficacy of mesenchymal stem cells (MSCs) as a virus vehicle has been reported in mouse models and canine and human patients, bu...
Autores principales: | Delgado-Bonet, Pablo, Tomeo-Martín, Beatriz Davinia, Ortiz-Díez, Gustavo, Perisé-Barrios, Ana Judith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9228126/ https://www.ncbi.nlm.nih.gov/pubmed/35737337 http://dx.doi.org/10.3390/vetsci9060285 |
Ejemplares similares
-
Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients
por: Martín-Carrasco, Clara, et al.
Publicado: (2022) -
Intracranial Virotherapy for a Canine Hemangioma
por: Delgado-Bonet, Pablo, et al.
Publicado: (2022) -
Humoral responses to SARS-CoV-2 by healthy and sick dogs during the COVID-19 pandemic in Spain
por: Perisé-Barrios, Ana Judith, et al.
Publicado: (2021) -
Biodistribution Analysis of Oncolytic Adenoviruses in Canine Patient Necropsy Samples Treated with Cellular Virotherapy
por: Gómez, Ana, et al.
Publicado: (2020) -
Systemic cellular viroimmunotherapy for canine high-grade gliomas
por: Cloquell, Ana, et al.
Publicado: (2022)